Abstract
Copper is an essential trace element for many important cellular functions. However, excess of copper can impair cellular functions by copper-induced oxidative stress. In brain, astrocytes are considered to play a prominent role in the copper homeostasis. In this short review we summarise the current knowledge on the molecular mechanisms which are involved in the handling of copper by astrocytes. Cultured astrocytes efficiently take up copper ions predominantly by the copper transporter Ctr1 and the divalent metal transporter DMT1. In addition, copper oxide nanoparticles are rapidly accumulated by astrocytes via endocytosis. Cultured astrocytes tolerate moderate increases in intracellular copper contents very well. However, if a given threshold of cellular copper content is exceeded after exposure to copper, accelerated production of reactive oxygen species and compromised cell viability are observed. Upon exposure to sub-toxic concentrations of copper ions or copper oxide nanoparticles, astrocytes increase their copper storage capacity by upregulating the cellular contents of glutathione and metallothioneins. In addition, cultured astrocytes have the capacity to export copper ions which is likely to involve the copper ATPase 7A. The ability of astrocytes to efficiently accumulate, store and export copper ions suggests that astrocytes have a key role in the distribution of copper in brain. Impairment of this astrocytic function may be involved in diseases which are connected with disturbances in brain copper metabolism.
Similar content being viewed by others
References
Liu J, Chakraborty S, Hosseinzadeh P, Yu Y, Tian S, Petrik I, Bhagi A, Lu Y (2014) Metalloproteins containing cytochrome, iron-sulfur, or copper redox centers. Chem Rev 114:4366–4469
Scheiber IF, Dringen R (2013) Astrocyte functions in the copper homeostasis of the brain. Neurochem Int 62:556–565
Scheiber IF, Mercer JF, Dringen R (2014) Metabolism and functions of copper in brain. Prog Neurobiol 116:33–57
Gulec S, Collins JF (2014) Molecular mediators governing iron-copper interactions. Annu Rev Nutr 34:95–116
Lovejoy DB, Guillemin GJ (2014) The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosis. Front Aging Neurosci 6:173
Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283:65–87
Romero A, Ramos E, de Los Rios C, Egea J, Del Pino J, Reiter RJ (2014) A review of metal-catalyzed molecular damage: protection by melatonin. J Pineal Res 56:343–370
Allen NJ (2014) Astrocyte regulation of synaptic behavior. Annu Rev Cell Dev Biol 30:439–463
Haydon PG, Nedergaard M (2015) How do astrocytes participate in neural plasticity? Cold Spring Harb Perspect Biol 7:a020438
Kaczor P, Rakus D, Mozrzymas JW (2015) Neuron-astrocyte interaction enhance GABAergic synaptic transmission in a manner dependent on key metabolic enzymes. Front Cell Neurosci 9:120
Rossi D (2015) Astrocyte physiopathology: at the crossroads of intercellular networking, inflammation and cell death. Prog Neurobiol 130:86–120
Verkhratsky A, Nedergaard M, Hertz L (2015) Why are astrocytes important? Neurochem Res 40:389–401
Brekke E, Morken TS, Sonnewald U (2015) Glucose metabolism and astrocyte-neuron interactions in the neonatal brain. Neurochem Int 82:33–41
Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35
Butt AM, Fern RF, Matute C (2014) Neurotransmitter signaling in white matter. Glia 62:1762–1779
Dringen R, Brandmann M, Hohnholt MC, Blumrich EM (2015) Glutathione-dependent detoxification processes in astrocytes. Neurochem Res. doi:10.1007/s11064-014-1481-1
Dringen R, Spiller S, Neumann S, Koehler Y (2015) Uptake, metabolic effects and toxicity of arsenate and arsenite in astrocytes. Neurochem Res. doi:10.1007/s11064-015-1570-9
Rodriguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A (2015) Astrocytes in physiological aging and Alzheimer’s disease. Neuroscience. doi:10.1016/j.neuroscience.2015.01.007
Verkhratsky A, Parpura V (2015) Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders. Neurobiol Dis. doi:10.1016/j.nbd.2015.03.025
Kodama H (1993) Recent developments in Menkes disease. J Inherit Metab Dis 16:791–799
Kodama H, Meguro Y, Abe T, Rayner MH, Suzuki KT, Kobayashi S, Nishimura M (1991) Genetic expression of Menkes disease in cultured astrocytes of the macular mouse. J Inherit Metab Dis 14:896–901
Szerdahelyi P, Kasa P (1986) Histochemical demonstration of copper in normal rat brain and spinal cord. Evidence of localization in glial cells. Histochemistry 85:341–347
Haywood S, Paris J, Ryvar R, Botteron C (2008) Brain copper elevation and neurological changes in north ronaldsay sheep: a model for neurodegenerative disease? J Comp Pathol 139:252–255
Bulcke F, Thiel K, Dringen R (2014) Uptake and toxicity of copper oxide nanoparticles in cultured primary brain astrocytes. Nanotoxicology 8:775–785
Hare DJ, Grubman A, Ryan TM, Lothian A, Liddell JR, Grimm R, Matsuda T, Doble PA, Cherny RA, Bush AI, White AR, Masters CL, Roberts BR (2013) Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry. Metallomics 5:1656–1662
Scheiber IF, Mercer JF, Dringen R (2010) Copper accumulation by cultured astrocytes. Neurochem Int 56:451–460
Scheiber IF, Schmidt MM, Dringen R (2010) Zinc prevents the copper-induced damage of cultured astrocytes. Neurochem Int 57:314–322
Scheiber IF, Dringen R (2011) Copper-treatment increases the cellular GSH content and accelerates GSH export from cultured rat astrocytes. Neurosci Lett 498:42–46
Scheiber IF, Dringen R (2011) Copper accelerates glycolytic flux in cultured astrocytes. Neurochem Res 36:894–903
Scheiber IF, Schmidt MM, Dringen R (2012) Copper export from cultured astrocytes. Neurochem Int 60:292–300
Qian Y, Zheng Y, Taylor R, Tiffany-Castiglioni E (2012) Involvement of the molecular chaperone Hspa5 in copper homeostasis in astrocytes. Brain Res 1447:9–19
Bulcke F, Santofimia-Castano P, Gonzalez-Mateos A, Dringen R (2015) Modulation of copper accumulation and copper-induced toxicity by antioxidants and copper chelators in cultured primary brain astrocytes. J Trace Elem Med Biol 32:168–176
Bulcke F, Dringen R (2015) Copper oxide nanoparticles stimulate glycolytic flux and increase the cellular contents of glutathione and metallothioneins in cultured astrocytes. Neurochem Res 40:15–26
Evans P, Matsunaga H, Kiguchi M (2008) Large-scale application of nanotechnology for wood protection. Nat Nanotechnol 3:577
Hanagata N, Zhuang F, Connolly S, Li J, Ogawa N, Xu M (2011) Molecular responses of human lung epithelial cells to the toxicity of copper oxide nanoparticles inferred from whole genome expression analysis. ACS Nano 5:9326–9338
Li CW, Ciston J, Kanan MW (2014) Electroreduction of carbon monoxide to liquid fuel on oxide-derived nanocrystalline copper. Nature 508:504–507
Patil PR, Krishnamurthy VN, Joshi SS (2008) Effect of nano-copper oxide and copper chromite on the thermal decomposition of ammonium perchlorate. Propellants Explos Pyrotech 33:266–270
Rubilar O, Rai M, Tortella G, Diez MC, Seabra AB, Duran N (2013) Biogenic nanoparticles: copper, copper oxides, copper sulphides, complex copper nanostructures and their applications. Biotechnol Lett 35:1365–1375
Ahmad Z, Vargas-Reus MA, Bakhshi R, Ryan F, Ren GG, Oktar F, Allaker RP (2012) Antimicrobial properties of electrically formed elastomeric polyurethane-copper oxide nanocomposites for medical and dental applications. Methods Enzymol 509:87–99
Ben-Sasson M, Zodrow KR, Genggeng Q, Kang Y, Giannelis EP, Elimelech M (2014) Surface functionalization of thin-film composite membranes with copper nanoparticles for antimicrobial surface properties. Environ Sci Technol 48:384–393
Dankovich TA, Smith JA (2014) Incorporation of copper nanoparticles into paper for point-of-use water purification. Water Res 63:245–251
Xu J, Li Z, Xu P, Xiao L, Yang Z (2013) Nanosized copper oxide induces apoptosis through oxidative stress in podocytes. Arch Toxicol 87:1067–1073
Karlsson HL, Cronholm P, Gustafsson J, Moller L (2008) Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 21:1726–1732
Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
Balkhyour MA, Goknil MK (2010) Total fume and metal concentrations during welding in selected factories in Jeddah, Saudi Arabia. Int J Environ Res Public Health 7:2978–2987
Szymczak W, Menzel N, Keck L (2007) Emission of ultrafine copper particles by universal motors controlled by phase angle modulation. J Aerosol Sci 38:520–531
Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdorster G, Ziesenis A (2002) Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65:1513–1530
Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445
Sharma HS, Sharma A (2012) Neurotoxicity of engineered nanoparticles from metals. CNS Neurol Disord Drug Targets 11:65–80
Yim YS, Choi JS, Kim GT, Kim CH, Shin TH, Kim DG, Cheon J (2012) A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB). Chem Commun (Camb) 48:61–63
Gromnicova R, Davies HA, Sreekanthreddy P, Romero IA, Lund T, Roitt IM, Phillips JB, Male DK (2013) Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro. PLoS ONE 8:e81043
An L, Liu S, Yang Z, Zhang T (2012) Cognitive impairment in rats induced by nano-CuO and its possible mechanisms. Toxicol Lett 213:220–227
Haywood S, Vaillant C (2014) Overexpression of copper transporter CTR1 in the brain barrier of North Ronaldsay sheep: implications for the study of neurodegenerative disease. J Comp Pathol 150:216–224
Brown DR (2004) Role of the prion protein in copper turnover in astrocytes. Neurobiol Dis 15:534–543
Eisses JF, Chi Y, Kaplan JH (2005) Stable plasma membrane levels of hCTR1 mediate cellular copper uptake. J Biol Chem 280:9635–9639
Eisses JF, Kaplan JH (2002) Molecular characterization of hCTR1, the human copper uptake protein. J Biol Chem 277:29162–29171
Lee J, Petris MJ, Thiele DJ (2002) Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. J Biol Chem 277:40253–40259
Qian Y, Tiffany-Castiglioni E (2003) Lead-induced endoplasmic reticulum (ER) stress responses in the nervous system. Neurochem Res 28:153–162
Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482–488
Jeong SY, David S (2003) Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278:27144–27148
Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M, Gonzalez-Billault C, Nunez MT (2013) Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 126:541–549
Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR (2001) Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 66:1198–1207
Brown LR, Harris DA (2003) Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi. J Neurochem 87:353–363
Pauly PC, Harris DA (1998) Copper stimulates endocytosis of the prion protein. J Biol Chem 273:33107–33110
Arredondo M, Munoz P, Mura CV, Nunez MT (2003) DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am J Physiol Cell Physiol 284:C1525–C1530
Tulpule K, Robinson SR, Bishop GM, Dringen R (2010) Uptake of ferrous iron by cultured rat astrocytes. J Neurosci Res 88:563–571
Gomes IM, Maia CJ, Santos CR (2012) STEAP proteins: from structure to applications in cancer therapy. Mol Cancer Res 10:573–587
Ohgami RS, Campagna DR, McDonald A, Fleming MD (2006) The steap proteins are metalloreductases. Blood 108:1388–1394
Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34:11929–11947
Harrison FE, May JM (2009) Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 46:719–730
Rice ME (2012) Brain ascorbate: protective, yet permissive for redox signaling. In: Choi I-J, Gruetter R (eds) Advances in neurobiology 4: neural metabolism in vivo. Springer, Heidelberg, pp 1051–1073
Lane DJ, Lawen A (2013) The glutamate aspartate transporter (GLAST) mediates L-glutamate-stimulated ascorbate-release via swelling-activated anion channels in cultured neonatal rodent astrocytes. Cell Biochem Biophys 65:107–119
Wilson JX, Peters CE, Sitar SM, Daoust P, Gelb AW (2000) Glutamate stimulates ascorbate transport by astrocytes. Brain Res 858:61–66
Geppert M, Petters C, Thiel K, Dringen R (2013) The presence of serum alters the properties of iron oxide nanoparticles and lowers their accumulation by cultured brain astrocytes. J Nanopart Res 15:1–15
Luther EM, Koehler Y, Diendorf J, Epple M, Dringen R (2011) Accumulation of silver nanoparticles by cultured primary brain astrocytes. Nanotechnology 22:375101
Geppert M, Hohnholt MC, Thiel K, Nurnberger S, Grunwald I, Rezwan K, Dringen R (2011) Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22:145101
Lamkowsky MC, Geppert M, Schmidt MM, Dringen R (2012) Magnetic field-induced acceleration of the accumulation of magnetic iron oxide nanoparticles by cultured brain astrocytes. J Biomed Mater Res A 100:323–334
Hohnholt MC, Geppert M, Luther EM, Petters C, Bulcke F, Dringen R (2013) Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem Res 38:227–239
Chen SH, Lin JK, Liu SH, Liang YC, Lin-Shiau SY (2008) Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol Sci 102:138–149
Reddy PV, Rao KV, Norenberg MD (2008) The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes. Lab Invest 88:816–830
Dringen R, Pawlowski PG, Hirrlinger J (2005) Peroxide detoxification by brain cells. J Neurosci Res 79:157–165
Hirrlinger J, Dringen R (2010) The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev 63:177–188
Jiang J, St Croix CM, Sussman N, Zhao Q, Pitt BR, Kagan VE (2002) Contribution of glutathione and metallothioneins to protection against copper toxicity and redox cycling: quantitative analysis using MT+/+ and MT−/− mouse lung fibroblast cells. Chem Res Toxicol 15:1080–1087
Petters C, Irrsack E, Koch M, Dringen R (2014) Uptake and metabolism of iron oxide nanoparticles in brain cells. Neurochem Res 39:1648–1660
Han X, Gelein R, Corson N, Wade-Mercer P, Jiang J, Biswas P, Finkelstein JN, Elder A, Oberdorster G (2011) Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology 287:99–104
Krotkiewska B, Banas T (1992) Interaction of Zn2+ and Cu2+ ions with glyceraldehyde-3-phosphate dehydrogenase from bovine heart and rabbit muscle. Int J Biochem 24:1501–1505
Lai JC, Blass JP (1984) Neurotoxic effects of copper: inhibition of glycolysis and glycolytic enzymes. Neurochem Res 9:1699–1710
Takahashi S, Abe T, Gotoh J, Fukuuchi Y (2002) Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons. Neurochem Int 40:441–448
Sheline CT, Choi EH, Kim-Han JS, Dugan LL, Choi DW (2002) Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann Neurol 52:195–204
Ferretti G, Bacchetti T, Moroni C, Vignini A, Curatola G (2003) Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins. Biochim Biophys Acta 1635:48–54
Pickard MR, Jenkins SI, Koller CJ, Furness DN, Chari DM (2011) Magnetic nanoparticle labeling of astrocytes derived for neural transplantation. Tissue Eng Part C Methods 17:89–99
Rademacher T, Male DK (2014) Nanoparticle delivery compositions. US Patent US20140227186 A1
Petters C, Thiel K, Dringen R (2015) Lysosomal iron libaration is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes. Nanotoxicology. doi:10.3109/17435390.2015.1071445
Chiang HS, Maric M (2011) Lysosomal thiol reductase negatively regulates autophagy by altering glutathione synthesis and oxidation. Free Radic Biol Med 51:688–699
de Duve C (1983) Lysosomes revisited. Eur J Biochem 137:391–397
Wang Z, von dem Bussche A, Kabadi PK, Kane AB, Hurt RH (2013) Biological and environmental transformations of copper-based nanomaterials. ACS Nano 7:8715–8727
Kim H, Wu X, Lee J (2013) SLC31 (CTR) family of copper transporters in health and disease. Mol Aspects Med 34:561–570
Pelizzoni I, Zacchetti D, Smith CP, Grohovaz F, Codazzi F (2012) Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. J Neurochem 120:269–278
Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O’Halloran TV (1999) Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284:805–808
Robinson NJ, Winge DR (2010) Copper metallochaperones. Annu Rev Biochem 79:537–562
Dringen R, Hamprecht B (1998) Glutathione restoration as indicator for cellular metabolism of astroglial cells. Dev Neurosci 20:401–407
Aschner M, Conklin DR, Yao CP, Allen JW, Tan KH (1998) Induction of astrocyte metallothioneins (MTs) by zinc confers resistance against the acute cytotoxic effects of methylmercury on cell swelling, Na+ uptake, and K+ release. Brain Res 813:254–261
Aschner M, Lorscheider FL, Cowan KS, Conklin DR, Vimy MJ, Lash LH (1997) Metallothionein induction in fetal rat brain and neonatal primary astrocyte cultures by in utero exposure to elemental mercury vapor (Hg0). Brain Res 778:222–232
Lee SJ, Koh JY (2010) Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain 3:30
Dineley KE, Scanlon JM, Kress GJ, Stout AK, Reynolds IJ (2000) Astrocytes are more resistant than neurons to the cytotoxic effects of increased [Zn(2+)]i. Neurobiol Dis 7:310–320
Luther EM, Schmidt MM, Diendorf J, Epple M, Dringen R (2012) Upregulation of metallothioneins after exposure of cultured primary astrocytes to silver nanoparticles. Neurochem Res 37:1639–1648
Speisky H, Gomez M, Burgos-Bravo F, Lopez-Alarcon C, Jullian C, Olea-Azar C, Aliaga ME (2009) Generation of superoxide radicals by copper-glutathione complexes: redox-consequences associated with their interaction with reduced glutathione. Bioorg Med Chem 17:1803–1810
Vasak M, Meloni G (2011) Chemistry and biology of mammalian metallothioneins. J Biol Inorg Chem 16:1067–1078
Telianidis J, Hung YH, Materia S, Fontaine SL (2013) Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front Aging Neurosci 5:44
La Fontaine S, Mercer JF (2007) Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys 463:149–167
Kim BE, Petris MJ (2007) Phenotypic diversity of Menkes disease in mottled mice is associated with defects in localisation and trafficking of the ATP7A protein. J Med Genet 44:641–646
Kaler SG (2011) ATP7A-related copper transport diseases-emerging concepts and future trends. Nat Rev Neurol 7:15–29
Tiffany-Castiglioni E, Hong S, Qian Y (2011) Copper handling by astrocytes: insights into neurodegenerative diseases. Int J Dev Neurosci 29:811–818
Choo XY, Alukaidey L, White AR, Grubman A (2013) Neuroinflammation and copper in Alzheimer’s disease. Int J Alzheimers Dis 2013:145345
Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ (2009) Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med 30:86–98
Kranich O, Dringen R, Sandberg M, Hamprecht B (1998) Utilization of cysteine and cysteine precursors for the synthesis of glutathione in astroglial cultures: preference for cystine. Glia 22:11–18
Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R (2006) The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem 97:373–384
Tadepalle N, Koehler Y, Brandmann M, Meyer N, Dringen R (2014) Arsenite stimulates glutathione export and glycolytic flux in viable primary rat brain astrocytes. Neurochem Int 76:1–11
Hirrlinger J, Schulz JB, Dringen R (2002) Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J Neurosci Res 69:318–326
Tulpule K, Schmidt MM, Boecker K, Goldbaum O, Richter-Landsberg C, Dringen R (2012) Formaldehyde induces rapid glutathione export from viable oligodendroglial OLN-93 cells. Neurochem Int 61:1302–1313
D’Ambrosi N, Rossi L (2015) Copper at synapse: release, binding and modulation of neurotransmission. Neurochem Int. doi:10.1016/j.neuint.2015.07.006
Tiffany-Castiglion E, Qian Y (2001) Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release. Neurotoxicology 22:577–592
Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, Aaseth J (2015) The neurotoxicity of iron, copper and manganese in Parkinson’s and Wilson’s diseases. J Trace Elem Med Biol 31:193–203
Scheiber IF, Dringen R, Mercer JFB (2013) Copper: effects of deficiency and overload. Met Ions Life Sci 13:359–387
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Special Issue: 40th Year of Neurochemical Research.
Rights and permissions
About this article
Cite this article
Bulcke, F., Dringen, R. Handling of Copper and Copper Oxide Nanoparticles by Astrocytes. Neurochem Res 41, 33–43 (2016). https://doi.org/10.1007/s11064-015-1688-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-015-1688-9